Institut des Maladies Neurodégénératives (IMN)

L’Institut des Maladies Neurodégénératives (IMN) (UMR 5293) est une Unité Mixte de Recherche associant l’Université de Bordeaux et le CNRS. Il regroupe 11 équipes de recherches fondamentale et préclinique et d’une équipe de Recherche clinique adossée au CHU de Bordeaux. L’IMN associe recherche fondamentale, préclinique et clinique dans le but de :

-Développer de nouvelles approches thérapeutiques des maladies neurodégénératives en facilitant la recherche translationnelle du laboratoire au lit du patient.

-D’accroître sa visibilité et son attractivité dans le champ des neurosciences translationnelles (Maladie de Parkinson et syndromes parkinsoniens atypiques, maladie d’Alzheimer, troubles obsessionnels compulsifs, etc.) et fondamentales (planification, cognition, contrôle moteur, substrats moléculaires de la transmission synaptique) en s’appuyant sur le potentiel de ses équipes et la dynamique mise en place depuis sa création.

Site Web

Lien scanR

	2020	2021	2022	2023	2024
Actes de congrès/Proceedings	0	0	0	0	0
Article de blog scientifique	0	0	0	0	0
Article de revue	5	12	12	20	19
Autre document	0	0	0	0	0
Brevet	0	0	0	0	0
Chapitre d'ouvrage	0	0	0	0	0
Communication dans un congrès	0	0	0	0	0
Document de travail - Pré-publication	0	0	0	1	0
HDR	0	0	0	0	0
Notice d'encyclopédie ou de dictionnaire	0	0	0	0	0
N°spécial de revue/special issue	0	0	0	0	0
Ouvrage	0	0	0	0	0
Poster	0	0	0	0	0
Rapport	0	0	0	0	0
Thèse d'exercice	0	0	0	0	0
Thèses de doctorat	3	4	2	0	0
Traduction	0	0	0	0	0

Institut des Maladies Neurodégénératives (IMN) - UMR 5293

Parcourir par

Dépôts récents

Adverse childhood experiences and left hippocampal volumetric reductions: A structural magnetic resonance imaging study

GAP43 Located on Corticostriatal Terminals Restrains Novelty-Induced Hyperactivity in Mice

Are we ready to cure post-stroke cognitive impairment? Many key prerequisites can be achieved quickly and easily

Explaining the Variability of Alzheimer Disease Fluid Biomarker Concentrations in Memory Clinic Patients Without Dementia

The pattern of cortical thickness associated with executive dysfunction in MCI and SCC: The MEMENTO cohort

Trial of Lixisenatide in Early Parkinson’s Disease

Diffusion imaging genomics provides novel insight into early mechanisms of cerebral small vessel disease

Association of LIfestyle for BRAin health risk score (LIBRA) and genetic susceptibility with incident dementia and cognitive decline

Genetic variants for head size share genes and pathways with cancer

Modulate the impact of the drowsiness on the resting state functional connectivity

Genome sequence analyses identify novel risk loci for multiple system atrophy

Hypergravity Increases Blood-Brain Barrier Permeability to Fluorescent Dextran and Antisense Oligonucleotide in Mice

Addressing unmeasured confounders in cohort studies: Instrumental variable method for a time-fixed exposure on an outcome trajectory

A Pluridisciplinary Tracheostomy Weaning Protocol for Brain-Injured Patients, Outside of the Intensive Care Unit and Without Instrumental Assessment: Results of Pilot Study

Patient-perceived progression in multiple system atrophy: natural history of quality of life

Resective epilepsy surgery and its impact on depression in adults: a systematic review, meta-analysis, and implications for future research

Effect of a Speaking Valve on Nasal Airflow During Tracheostomy Weaning: A Case Series

Disease Progression in Multiple System Atrophy: The Value of Clinical Cohorts with Long Follow-Up

Lifespan neurodegeneration of the human brain in multiple sclerosis

Craving dynamics and related cerebral substrates predict timing of use in alcohol, tobacco, and cannabis use disorders

Statistiques

Statistiques générales de la collection

Nombre de documents par année

Dépôs récents

Institut des Maladies Neurodégénératives (IMN) - UMR 5293

Parcourir par

Dépôts récents

Adverse childhood experiences and left hippocampal volumetric reductions: A structural magnetic resonance imaging study ﻿

GAP43 Located on Corticostriatal Terminals Restrains Novelty-Induced Hyperactivity in Mice ﻿

Are we ready to cure post-stroke cognitive impairment? Many key prerequisites can be achieved quickly and easily ﻿

Explaining the Variability of Alzheimer Disease Fluid Biomarker Concentrations in Memory Clinic Patients Without Dementia ﻿

The pattern of cortical thickness associated with executive dysfunction in MCI and SCC: The MEMENTO cohort ﻿

Trial of Lixisenatide in Early Parkinson’s Disease ﻿

Diffusion imaging genomics provides novel insight into early mechanisms of cerebral small vessel disease ﻿

Association of LIfestyle for BRAin health risk score (LIBRA) and genetic susceptibility with incident dementia and cognitive decline ﻿

Genetic variants for head size share genes and pathways with cancer ﻿

Modulate the impact of the drowsiness on the resting state functional connectivity ﻿

Genome sequence analyses identify novel risk loci for multiple system atrophy ﻿

Hypergravity Increases Blood-Brain Barrier Permeability to Fluorescent Dextran and Antisense Oligonucleotide in Mice ﻿

Addressing unmeasured confounders in cohort studies: Instrumental variable method for a time-fixed exposure on an outcome trajectory ﻿

A Pluridisciplinary Tracheostomy Weaning Protocol for Brain-Injured Patients, Outside of the Intensive Care Unit and Without Instrumental Assessment: Results of Pilot Study ﻿

Patient-perceived progression in multiple system atrophy: natural history of quality of life ﻿

Resective epilepsy surgery and its impact on depression in adults: a systematic review, meta-analysis, and implications for future research ﻿

Effect of a Speaking Valve on Nasal Airflow During Tracheostomy Weaning: A Case Series ﻿

Disease Progression in Multiple System Atrophy: The Value of Clinical Cohorts with Long Follow-Up ﻿

Lifespan neurodegeneration of the human brain in multiple sclerosis ﻿

Craving dynamics and related cerebral substrates predict timing of use in alcohol, tobacco, and cannabis use disorders ﻿